Cytochalasin B (CB) prevents cytoplasmic cleavage without directly affecting nuclear division. Secondary cultures of mouse embryo fibroblasts or 3T3 cells show controlled nuclear division when treated with CB: only binucleated cells are formed. Many CB-treated transformed cells show uncontrolled nuclear division and become highly multi-nucleated. When CB-treated normal cells are concurrently infected with high inputs of SV40, many of these cells become highly multinucleated. It is suggested that these highly multinucleated cells represent abortively transformed cells since the actual number of transforming units (focus-forming units) of simian virus 40 (SV40) is too low to account for the appearance of these cells. Also, if the CB treatment is begun 6 days after SV40 inoculation, the large increase in highly multinucleated cells is not observed. Most cells stably transformed by SV40 or adenovirus show uncontrolled nuclear division when treated with CB. However, 3T3 cells transformed by SV40 or adenovirus and analyzed shortly after transformation are an exception and show controlled nuclear division. This property of 3T3 cells is apparently overcome by high inputs of SV40 since abortively transformed cells become highly multinucleated.

Keywords:
Cytochalasin B, SV40 transformation, Abortive transformation, Nuclear division
This content is only available via PDF.
© 1976 S. Karger AG, Basel
1976
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.